Cargando…
RS3PE Syndrome with Subsequent PMR Caused by Long-Term DPP-4 Inhibitor Use
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome has been reported in patients treated with dipeptidyl peptidase-4 inhibitors (DPP-4i). We experienced a case of RS3PE syndrome in a 73-year-old man with a history of type 2 diabetes, who developed RS3PE as a side effec...
Autores principales: | Takahashi, Yuichi, Deshpande, Gautam A., Kanai, Yoshinori, Seok Yan, Kwang, Naito, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348439/ https://www.ncbi.nlm.nih.gov/pubmed/37455697 http://dx.doi.org/10.12890/2023_003914 |
Ejemplares similares
-
The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan
por: Okumura, Toshikatsu, et al.
Publicado: (2011) -
Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021) -
The Characterization of Two-Component System PmrA/PmrB in Cronobacter sakazakii
por: Hua, Jingjing, et al.
Publicado: (2020) -
Discovery and Characterization of Polymyxin-Resistance Genes pmrE and pmrF from Sediment and Seawater Microbiome
por: Joo, Hwanjin, et al.
Publicado: (2023) -
RS3PE in Association With Dipeptidyl Peptidase-4 Inhibitor: Report of Two Cases
por: Yamauchi, Keishi, et al.
Publicado: (2012)